Vivos Therapeutics (VVOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

While vivo has long been known for its gaming-ready phones, the new vivo V60 Lite adds another dimension to the mix: a ...

THE vivo X300 Pro has achieved exceptional results in the latest DxOMark Camera Test, earning a global score of 171 and ...

Vivo is set to introduce the X200T smartphone, positioned between the X200 FE and X300 models, following the recent launch of ...

Vivo's device list easily reads as a best of the best, yet the maker finished fourth in market share. 2025 was a good year ...

The iQOO 15 Ultra will feature the largest active cooling fan ever, shoulder buttons, and Snapdragon 8 Elite Gen 5 for ...

Looking for the best camera phones in 2026? Here are five Vivo X300 Pro alternatives, including iPhone 17 Pro, Samsung Galaxy ...

It looks like the Vivo X200 series will see a new addition in the form of the Vivo X200T, as reports state that the device ...

"Nia Therapeutics publishes first in vivo validation of SNS" was originally created and published by Medical Device Network, ...

The Vivo X200T will feature a Dimensity 9400+ processor, large battery, Zeiss triple rear cameras and long software support; ...

Y50s 5G and Y50e 5G, sharing a large 6000mAh battery and 6.74-inch display with different RAM, storage, charging speeds and pricing.

Vivo is preparing to launch two new phones in India, likely the Vivo X300 FE and Vivo X200T. BIS approvals suggest a January ...